Fresenius Medical Care Announces Record Dividend and Strategic Milestones at AGM

Fresenius Medical Care ( (FMS) ) has issued an update.

On May 22, 2025, Fresenius Medical Care announced at its Annual General Meeting that it achieved significant milestones in 2024, including a 21% increase in dividends per share, marking the highest in the company’s history. The company reported a 4% organic revenue growth and an 18% increase in operating income, positioning it well for double-digit earnings growth in 2025. The AGM approved various financial authorizations, including a new dividend and capital structure adjustments, reflecting strong shareholder confidence. The company also highlighted its strategic transformation efforts, including the successful FDA clearance of the 5008X hemodiafiltration machine, which sets a new standard of care in the U.S.

The most recent analyst rating on (FMS) stock is a Hold with a $30.00 price target. To see the full list of analyst forecasts on Fresenius Medical Care stock, see the FMS Stock Forecast page.

Spark’s Take on FMS Stock

According to Spark, TipRanks’ AI Analyst, FMS is a Outperform.

Fresenius Medical Care demonstrates solid financial performance with consistent revenue and strong cash flow. Positive momentum is evident in technical indicators, although valuation metrics suggest potential overvaluation. The company’s strategic initiatives and earnings call guidance support a positive outlook for the year.

To see Spark’s full report on FMS stock, click here.

More about Fresenius Medical Care

Fresenius Medical Care is the world’s leading provider of products and services for individuals with renal diseases, with around 4.2 million patients worldwide undergoing dialysis treatment. The company operates a network of 3,674 dialysis clinics, providing treatments for approximately 299,000 patients globally. Fresenius Medical Care is also a leading provider of dialysis products such as machines and dialyzers, and is listed on the Frankfurt Stock Exchange and the New York Stock Exchange.

Average Trading Volume: 446,928

Technical Sentiment Signal: Buy

Current Market Cap: $17.39B

For a thorough assessment of FMS stock, go to TipRanks’ Stock Analysis page.